Endolytix Technology
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
48 Dunham Rd Ste 5850, Beverly, Massachu...Website
endolytx.bioRevenue
<$5 MillionIndustry
About Endolytix Technology
Is Endolytix Technology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Endolytix Technology
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Endolytix Technology has new funding data
Check if Endolytix Technology has recently received funding, and reach out quickly before it becomes old news!
Click to see if Endolytix Technology had a recent Job posting/layoffs
Check out if Endolytix Technology is spiking on competitors!
Earning: See what the market has to say on Endolytix Technology recently announced quarterly report
Endolytix Technology, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Endolytix Technology launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Endolytix Technology
Compare insights from companies similar to Endolytix Technology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Endolytix Technology
Endolytix Technology Tech Stack
A closer look at the technologies used by Endolytix Technology
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Endolytix Technology
Endolytix Technology, Inc is focused on developing innovative therapeutics to combat antibiotic resistance, particularly in nontuberculous mycobacterial infections. With a growing incidence of these infections, the company aims to provide effective treatment options for patients who have limited alternatives. Their unique approach targets intracell... Read More